Coral Laboratories Reports Declining Financial Results, Raising Concerns Over Sustainability in March 2025

Coral Laboratories, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending March 2025. The results indicate a notable shift in the company's financial landscape, with a revision in its score reflecting the challenges faced during this period.
The Profit Before Tax less Other Income (PBT) for the quarter stands at Rs 2.14 crore, marking a significant decline compared to the previous year. Similarly, the Profit After Tax (PAT) has also shown a downward trend, recorded at Rs 3.40 crore. The operating profit, measured as PBDIT, has reached its lowest point in the last five quarters at Rs 2.68 crore, indicating a concerning trend in operational efficiency.

Additionally, the operating profit margin has decreased to 9.53%, the lowest observed in recent quarters, suggesting a deterioration in the company's efficiency. The reliance on non-operating income, which constitutes a substantial portion of the PBT, raises questions about the sustainability of the business model. Furthermore, the Earnings per Share (EPS) has fallen to Rs 7.93, reflecting a decline in profitability and lower returns for shareholders.

In light of these developments, Coral Laboratories has experienced evaluation changes that warrant attention.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.